Skip to main content
. Author manuscript; available in PMC: 2016 May 13.
Published in final edited form as: Pharmacogenomics. 2009 Mar;10(3):339–344. doi: 10.2217/14622416.10.3.339

Table 2.

SLCO1A2 genetic polymorphisms.

Exon Position Base pair change AA position AA change dbSNP Id Nomenclature/function
Lee et al. [16] (ES, Delt II, DPDPE) Badagnani et al. [33] (ES, MTX)
1 38 T>C 13 I>T rs10841795 *2 1.1 (↑ both)
51 C>T S S rs11568572
186 T>C S S rs2306227
4 382 A>T 128 N>Y rs11568567 *5 4.1
4 404 A>T 135 N>I rs45502302 *6 (↓ all) 4.2
5 502 C>T 168 R>C rs11568564 5.1 (↓ both)
5 516 A>C 172 E>D rs11568563 *3 (↓ all) 5.2 (↓ both)
5 559 G>A 187 A>Y NA *4 (↓ Delt II only)
726 C>T S S rs11045953
768 C>T S S NA
7 830 C>A 277 T>N NA 7.3
7 833 A>– 278 N>del NA 7.4 (↓ both)
837 T>G S S NA
7 841 A>G 281 I>V rs11568551 7.6
8 968 T>C 323 L>P rs11568579 8.2
8 1063 A>G 355 I>V rs45628437 8.3
1380 A>G S S rs3764044
1662 C>T S S rs2417971
14 2003 C>G 668 T>S rs11568557 *7 14.2

↑: Increased function; ↓: Decreased function; AA: Amino acid; Delt II: Deltorphin II; dbSNP: SNP database; DPDPE: (D-Pen2,D-Pen5)-Enkephalin; ES: Estrone Sulfate; MTX: Methotrexate; NA: Not currently available; S: Synonymous.